Immunoliposome-mediated targeting of anti-cancer drugs in vivo.
Allen
T M
TM
Department of Pharmacology, University of Alberta, Edmonton, Canada.
Ahmad
I
I
Lopes de Menezes
D E
DE
Moase
E H
EH
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D018796:Immunoconjugates / Q000008:administration & dosage*; D008081:Liposomes; D008175:Lung Neoplasms / Q000188:drug therapy; D016393:Lymphoma, B-Cell / Q000188:drug therapy; D051379:Mice; D008807:Mice, Inbred BALB C; D008811:Mice, Inbred DBA; D008819:Mice, Nude; D016513:Mice, SCID; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy; D010051:Ovarian Neoplasms / Q000188:drug therapy; D014183:Transplantation, Heterologous; D014407:Tumor Cells, Cultured
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D018796:Immunoconjugates; D008081:Liposomes; D004317:Doxorubicin